Operating income increased 42.4%
Operating income changed +42.4% from the comparable as-filed period.
-$44.1M→-$25.4M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ADCT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets decreased 13.1%
Total assets changed -13.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$321.6M→$279.4M4 prior comparisons
Current ratio decreased 38.6%
Current ratio changed -38.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
4.93→3.034 prior comparisons
Working capital / assets moved 1626 bp lower
Working capital / assets changed -1626 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
79.04%→62.77%4 prior comparisons
Operating margin moved 10772 bp higher
Operating margin changed +10772 basis points from the comparable as-filed period.
-244.11%→-136.39%3 prior comparisons
Current assets decreased 17.9%
Current assets changed -17.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$318.8M→$261.7M4 prior comparisons
Net income increased 70.8%
Net income changed +70.8% from the comparable as-filed period.
-$56.6M→-$16.6M3 prior comparisons
Cash & equivalents decreased 17.2%
Cash & equivalents changed -17.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$264.6M→$219.1M4 prior comparisons
Research & development decreased 42.3%
Research & development changed -42.3% from the comparable as-filed period.
$30.1M→$17.4M3 prior comparisons
SBC / revenue moved 1440 bp higher
SBC / revenue changed +1440 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
10.01%→24.42%3 prior comparisons
Inventory decreased 72.2%
Inventory changed -72.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$17.8M→$4.9M4 prior comparisons
Inventory / revenue moved 7175 bp lower
Inventory / revenue changed -7175 basis points from the comparable as-filed period.
98.22%→26.47%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.